CASTLE BIOSCIENCES INC (CSTL)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 150M 300M 450M FY18: 22.8M FY19: 51.9M FY20: 62.6M FY21: 94.1M FY22: 137M FY23: 219.8M FY24: 332.1M FY25: 344.2M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Gross Profit Annual

0 20M 40M 60M FY18: 17.5M FY19: 44.6M FY20: 53M FY18 FY19 FY20

Operating Income Annual

-75M -50M -25M 0 25M 50M 75M FY18: -3.8M FY19: 7.3M FY20: -6.5M FY21: -40.1M FY22: -72.9M FY23: -68M FY24: 8.7M FY25: -42.8M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Net Income Annual

-75M -50M -25M 0 25M 50M 75M FY18: -6.4M FY19: 5.3M FY20: -10.3M FY21: -31.3M FY22: -67.1M FY23: -57.5M FY24: 18.2M FY25: -24.2M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Cost of Revenue Annual

0 25M 50M 75M FY18: 5.3M FY19: 7.3M FY20: 9.7M FY21: 15.8M FY22: 32M FY23: 45M FY24: 60.2M FY25: 71M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating Cash Flow Annual

-50M -25M 0 25M 50M 75M FY18: -12.3M FY19: 7M FY20: 9.9M FY21: -19M FY22: -41.7M FY23: -5.6M FY24: 64.9M FY25: 64.3M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Free Cash Flow Annual

-60M -40M -20M 0 20M 40M 60M FY18: -12.6M FY19: 6.1M FY20: 5.1M FY21: -22.5M FY22: -47.3M FY23: -19.2M FY24: 36.5M FY25: 28.3M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 10M 20M 30M FY18: 1.9M FY19: 8.7M FY20: 18.9M FY21: 25.1M FY22: 26.1M FY23: 26.8M FY24: 29.3M FY25: 29M FY18 FY19 FY20 FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-7.50 -5.00 -2.50 0.00 2.50 5.00 7.50 Q4 '18: -6.47 Q1 '19: -5.32 Q2 '19: -4.22 Q3 '20: -0.17 Q4 '20: -0.51 Q1 '21: -0.71 Q2 '21: -0.98 Q3 '21: -1.22 Q4 '21: -1.24 Q1 '22: -2.04 Q2 '22: -1.75 Q3 '22: -2.05 Q4 '22: -2.59 Q1 '23: -2.72 Q2 '23: -3.36 Q3 '23: -2.85 Q4 '23: -2.15 Q1 '24: -1.14 Q2 '24: -0.13 Q3 '24: 0.21 Q4 '24: 0.62 Q1 '25: -0.19 Q2 '25: -0.35 Q3 '25: -0.45 Q4 '25: -0.83 Q1 '26: -0.42 Q2 '26: -0.64 Q2 '19 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.